Elevated endothelin-1 plasma concentration in patients with essential hypertension. 1994

A Januszewicz, and M Lapiński, and B Symonides, and E Dabrowska, and A Kuch-Wocial, and E Trzepla, and H Ignatowska-Switalska, and B Wocial, and J Chodakowska, and W Januszewicz
Department of Hypertension and Angiology, Academy of Medicine, Warsaw, Poland.

BACKGROUND Endothelin-1 (ET-1) may play an important role in the development and maintenance of hypertensive states. In patients with essential hypertension, ET-1 plasma concentration increases or remains unchanged. The aim of the present study was to investigate ET-1 plasma concentration in patients with mild-to-moderate essential hypertension and its interrelationship with catecholamines, neuropeptide Y and atrial natriuretic peptide (ANP). METHODS The study included 37 patients (mean age 38.2 +/- 1.6 years) with mild-to-moderate essential hypertension. The control group consisted of 21 healthy volunteers (mean age 35.6 +/- 1.4 years). ET-1, neuropeptide Y and ANP were determined by radioimmunoassay methods and catecholamine plasma concentration was determined radioenzymatically. RESULTS Our study shows that plasma ET-1 and neuropeptide Y levels are elevated in patients with essential hypertension compared with a control group. No correlation was found in either of the groups between plasma ET-1 level and plasma neuropeptide Y, catecholamine or ANP concentrations. CONCLUSIONS Our results suggest that ET-1 is relevant in the development and maintenance of elevated blood pressure.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016232 Endothelins 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides. Endothelium-Derived Vasoconstrictor Factors,Endothelin,Vasoconstrictor Factors, Endothelium-Derived

Related Publications

A Januszewicz, and M Lapiński, and B Symonides, and E Dabrowska, and A Kuch-Wocial, and E Trzepla, and H Ignatowska-Switalska, and B Wocial, and J Chodakowska, and W Januszewicz
March 1994, Clinical nephrology,
A Januszewicz, and M Lapiński, and B Symonides, and E Dabrowska, and A Kuch-Wocial, and E Trzepla, and H Ignatowska-Switalska, and B Wocial, and J Chodakowska, and W Januszewicz
January 2006, Przeglad lekarski,
A Januszewicz, and M Lapiński, and B Symonides, and E Dabrowska, and A Kuch-Wocial, and E Trzepla, and H Ignatowska-Switalska, and B Wocial, and J Chodakowska, and W Januszewicz
January 1977, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
A Januszewicz, and M Lapiński, and B Symonides, and E Dabrowska, and A Kuch-Wocial, and E Trzepla, and H Ignatowska-Switalska, and B Wocial, and J Chodakowska, and W Januszewicz
August 1999, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
A Januszewicz, and M Lapiński, and B Symonides, and E Dabrowska, and A Kuch-Wocial, and E Trzepla, and H Ignatowska-Switalska, and B Wocial, and J Chodakowska, and W Januszewicz
January 1990, The New England journal of medicine,
A Januszewicz, and M Lapiński, and B Symonides, and E Dabrowska, and A Kuch-Wocial, and E Trzepla, and H Ignatowska-Switalska, and B Wocial, and J Chodakowska, and W Januszewicz
July 1997, Journal of human hypertension,
A Januszewicz, and M Lapiński, and B Symonides, and E Dabrowska, and A Kuch-Wocial, and E Trzepla, and H Ignatowska-Switalska, and B Wocial, and J Chodakowska, and W Januszewicz
July 1992, Hepatology (Baltimore, Md.),
A Januszewicz, and M Lapiński, and B Symonides, and E Dabrowska, and A Kuch-Wocial, and E Trzepla, and H Ignatowska-Switalska, and B Wocial, and J Chodakowska, and W Januszewicz
December 1997, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
A Januszewicz, and M Lapiński, and B Symonides, and E Dabrowska, and A Kuch-Wocial, and E Trzepla, and H Ignatowska-Switalska, and B Wocial, and J Chodakowska, and W Januszewicz
March 2007, Circulation journal : official journal of the Japanese Circulation Society,
A Januszewicz, and M Lapiński, and B Symonides, and E Dabrowska, and A Kuch-Wocial, and E Trzepla, and H Ignatowska-Switalska, and B Wocial, and J Chodakowska, and W Januszewicz
November 2001, Hypertension research : official journal of the Japanese Society of Hypertension,
Copied contents to your clipboard!